Stratified analysis revealed that PD-L1 expression was significantly associated with adverse OS (P = 0.019, Figure 5A) and DFS (P = 0.014, Figure 5B) for patients with grade IV gliomas during the long-time survival or follow up. The gene discussed is CD274; the disease is glioma.